When the MDL was initially formed, the 161 cases were transferred to District Court of New Jersey. As recently as March 2019, there are more than 8,400 lawsuits pending, and more lawsuits are still being filed, although the first of the bellwether trials won’t take place until 2020.
But Seeing the number of cases being filed increases, the panel later reconsidered and officially formed MDL 2789 (PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (NO. II)) in August 2017.
To avoid trial, AstraZeneca eventually paid $20 million to plaintiffs who purchased Nexium between March 1, 2001 and February 6, 2013. Pfizer, Inc. paid $55 million to avoid trial in 2013 for allegedly engaging in unlawful marketing tactics designed to drive off-label use of the drug Protonix.
Other studies showed a 1.16-fold increase in heart attack risk and double the risk of cardiovascular mortality when compared to patients taking H2 blockers for heartburn relief Additional studies from Johns Hopkins University and the American Society of Nephrology linked long-term PPI use with a 20-50% increased risk of chronic kidney disease (CKD) and a […]